肝细胞癌
免疫组织化学
肝硬化
医学
阶段(地层学)
内科学
病理
信使核糖核酸
实时聚合酶链反应
临床意义
胃肠病学
肿瘤科
生物
基因
生物化学
古生物学
作者
Chenghui Zhou,Nianfeng Li
出处
期刊:PubMed
日期:2019-04-28
卷期号:44 (4): 406-412
被引量:1
标识
DOI:10.11817/j.issn.1672-7347.2019.04.010
摘要
To investigate the expression of zinc finger protein 207 (ZNF207) in hepatocellular carcinoma (HCC) tissues, and analyze the correlation of ZNF207 with clinicopathological factors and HCC patients' survival. Methods: Real-time PCR was used to detect ZNF207 mRNA expression in 10 paired fresh HCC and adjacent non-tumor liver tissue samples. Immunohistochemical (IHC) analysis was used to detect ZNF207 protein expression in 135 cases of randomly selected paraffin-embedded HCC tissues. The correlation of ZNF207 expression with clinicopathological factors and survival of HCC was analyzed. Results: The ZNF207 mRNA expression level in HCC was significantly higher than that in the adjacent non-tumor liver tissue (P<0.01). IHC results showed that ZNF207 protein level was elevated in HCC tissues and ZNF207 expression was correlated with cirrhosis, nodule number, tumor capsule, vascular invasion, and TNM stage (P<0.05). Survival analysis showed that patients with high ZNF207 expression had poorer overall survival (OS) and disease-free survival (DFS) than those with the low ZNF207 expression (P<0.01), and ZNF207 was an independent risk factor for OS and DFS of HCC (P<0.05). Conclusion: ZNF207 expression is elevated in HCC and associated with adverse clinicopathological factors, indicating poor prognosis for HCC.目的:研究锌指蛋白207(zinc finger protein 207,ZNF207)在人肝细胞癌(hepatocellular carcinoma,HCC)中的表达情况,分析其与HCC临床病理特征及预后的相关性。方法:选择10对新鲜的冰冻HCC组织及相应癌旁肝组织标本,采取real-time PCR检测其中ZNF207 mRNA的表达;另随机选择135例有完整资料的HCC石蜡标本,采用免疫组织化学检测其中ZNF207蛋白的表达;统计分析ZNF207的表达与HCC临床病理特征及预后的关系。结果:在新鲜冰冻HCC组织中ZNF207 mRNA的表达水平明显高于相应的癌旁肝组织(P<0.01);免疫组织化学结果显示HCC组织中ZNF207呈显著高表达;且ZNF207的表达与肝硬化、结节数目、肿瘤包膜、微血管侵犯以及TNM分期明显相关(P<0.05);生存分析显示ZNF207高表达组HCC患者总生存率、无瘤生存率较ZNF207低表达组明显下降(P<0.01);单多因素回归分析显示ZNF207是HCC患者总生存率及无瘤生存率的独立危险因素(P<0.05)。结论:ZNF207在HCC中呈高表达,与HCC不良临床病理特征密切相关,并预示不良预后。.
科研通智能强力驱动
Strongly Powered by AbleSci AI